Search

everythinglearnresearchcommunity

for

Search:↓

Primary care doctors should address female sexual dysfunctions to improve women's sexual health and life quality.

Melatonin implants and long daylight hours alter the timing of hormone release and hair growth in mouflon sheep.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

Finasteride helps reduce hidradenitis suppurativa symptoms in females.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

The document concludes that better research methods are needed in men's sexual health to provide stronger evidence and improve patient care.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Altered metabolism can help control seizures by changing brain signaling and energy use, suggesting new treatments for epilepsy.

Aging scalp skin contributes to hair aging and loss, and more research is needed to develop better hair loss treatments.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

The review found that individualized treatment and teamwork are important for trichotillomania, and patients who followed through with treatment often improved.

Nonshaven follicular unit extraction is a highly satisfactory method for restoring pubic hair.

The document explains various skin conditions and their treatments.

Nanocarriers like liposomes and cyclodextrins improve how angiotensin-(1-7) is delivered in the body.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Keratins help protect cells, aid in cancer diagnosis, and influence cancer behavior and treatment.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Blocking 5α-reductase can harm memory and brain structure, and increase harmful brain changes in male mice used for Alzheimer's disease research.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Electro-acupuncture may help treat PCOS in rats by changing brain DNA methylation.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.

Minocycline may cause hair loss by increasing DHT levels, but finasteride can help counteract this effect.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.